University of Michigan Hospitals-Michigan Medicine
BEA-17 Granted Orphan Drug Designation By FDA For The Treatment Of Glioblastoma
Inventory Of Fda-Approved Adc Drugs
Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy!
New Lymphoma Drug Approved! Half Of The Patients Had Significant Tumour Regression
Medipolis Proton Therapy Centre, Japan
